HTLV-I and HTLV-II infections in subjects at risk for HIV-I infection from southeastern Italy (Apulia region). NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HTLV-I and HTLV-II infections in subjects at risk for HIV-I infection from southeastern Italy (Apulia region).

Int J Cancer. 1996 Mar 15;65(6):746-50. Unique Identifier : AIDSLINE MED/96200256
Chironna M; Calabro ML; Quarto M; Germinario C; Fiore JR; Favero A; Potenza D; Chieco-Bianchi L; Barbuti S; Institute of Hygiene, University of Bari, Italy.


Abstract: To assess the prevalence of HTLV-I and HTLV-II infections in different groups at risk for HIV-I infection, a study on 867 subjects was carried out by means of serological and PCR analyses. Serum specimens were collected from 268 intravenous drug users (IVDU), 66 homosexual men, 248 subjects with sexually transmitted diseases (STD), 105 thalassemics and 180 hemophiliacs. Sera from 3 IVDU and a sample from an STD patient were confirmed as HTLV-II seropositive; a thalassemic patient was seropositive for HTLV-I; a homosexual man, though confirmed as HTLV-I/II-seroreactive, could not be typed by serological methods. No hemophiliac was found to be HTLV-I/II-reactive. All 3 HTLV-II-seroreactive IVDU and the HTLV-I-infected thalassemic were confirmed by PCR; an additional sample from an IVDU, indeterminate by Western blot, was confirmed to be positive for HTLV-II by PCR. Subtyping of HTLV-II samples indicated the presence of II/b subtype in all 4 cases. Up to now, the reservoir for HTLV-II infection in southeastern Italy is mainly represented by IVDU, while HTLV-I infection seems to be sporadic.
Keywords: Blotting, Western Human HIV Infections/*EPIDEMIOLOGY HIV Seroprevalence HIV-1 HTLV-I Infections/BLOOD/*EPIDEMIOLOGY HTLV-II/CLASSIFICATION HTLV-II Infections/BLOOD/*EPIDEMIOLOGY Italy/EPIDEMIOLOGY Male Polymerase Chain Reaction Prevalence Risk Factors Support, Non-U.S. Gov't JOURNAL ARTICLEKWDblotting,westernhumanhivinfections/KWDepidemiologyhivseroprevalencehiv-1htlv-iinfections/blood/KWDepidemiologyhtlv-ii/classificationhtlv-iiinfections/blood/KWDepidemiologyitaly/epidemiologymalepolymerasechainreactionprevalenceriskfactorssupport,non-uKWDsKWDgov'tjournalarticle
960930
M9690915

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .